

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 8.62593786 |
| 2 | actin-myosin filament sliding (GO:0033275) | 8.09253319 |
| 3 | muscle filament sliding (GO:0030049) | 8.09253319 |
| 4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.85405102 |
| 5 | cardiac myofibril assembly (GO:0055003) | 7.61748438 |
| 6 | myofibril assembly (GO:0030239) | 7.32847271 |
| 7 | regulation of skeletal muscle contraction (GO:0014819) | 6.99480430 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.94580780 |
| 9 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.93180081 |
| 10 | actin-mediated cell contraction (GO:0070252) | 6.66998012 |
| 11 | plasma membrane repair (GO:0001778) | 6.62685318 |
| 12 | tricarboxylic acid cycle (GO:0006099) | 6.60246012 |
| 13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.58085943 |
| 14 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.49009599 |
| 15 | cardiac muscle contraction (GO:0060048) | 6.23706236 |
| 16 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.11882849 |
| 17 | regulation of relaxation of muscle (GO:1901077) | 6.06649870 |
| 18 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.81494349 |
| 19 | cardiac muscle cell development (GO:0055013) | 5.69454699 |
| 20 | regulation of actin filament-based movement (GO:1903115) | 5.67556195 |
| 21 | striated muscle contraction (GO:0006941) | 5.60150253 |
| 22 | carnitine shuttle (GO:0006853) | 5.59352167 |
| 23 | regulation of cell communication by electrical coupling (GO:0010649) | 5.49437932 |
| 24 | actomyosin structure organization (GO:0031032) | 5.48227919 |
| 25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.46738765 |
| 26 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.38621347 |
| 27 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.37772420 |
| 28 | cardiac cell development (GO:0055006) | 5.33474395 |
| 29 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.29460965 |
| 30 | skeletal muscle contraction (GO:0003009) | 5.20233160 |
| 31 | regulation of sarcomere organization (GO:0060297) | 5.14133067 |
| 32 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.11219792 |
| 33 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.00496345 |
| 34 | actin filament-based movement (GO:0030048) | 4.98394457 |
| 35 | skeletal muscle fiber development (GO:0048741) | 4.95436330 |
| 36 | fatty acid transmembrane transport (GO:1902001) | 4.89904290 |
| 37 | cardiac muscle hypertrophy (GO:0003300) | 4.87727919 |
| 38 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.84201259 |
| 39 | regulation of cofactor metabolic process (GO:0051193) | 4.81488722 |
| 40 | regulation of coenzyme metabolic process (GO:0051196) | 4.81488722 |
| 41 | adult heart development (GO:0007512) | 4.78604034 |
| 42 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.76111453 |
| 43 | regulation of striated muscle contraction (GO:0006942) | 4.75410581 |
| 44 | heart trabecula formation (GO:0060347) | 4.69816455 |
| 45 | striated muscle hypertrophy (GO:0014897) | 4.69471655 |
| 46 | heart contraction (GO:0060047) | 4.66416527 |
| 47 | heart process (GO:0003015) | 4.66416527 |
| 48 | creatine metabolic process (GO:0006600) | 4.64908273 |
| 49 | myotube cell development (GO:0014904) | 4.59052085 |
| 50 | regulation of membrane repolarization (GO:0060306) | 4.55690491 |
| 51 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.50019611 |
| 52 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.46491380 |
| 53 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.45465644 |
| 54 | muscle tissue morphogenesis (GO:0060415) | 4.44734842 |
| 55 | glucan biosynthetic process (GO:0009250) | 4.29004798 |
| 56 | glycogen biosynthetic process (GO:0005978) | 4.29004798 |
| 57 | respiratory electron transport chain (GO:0022904) | 4.27189104 |
| 58 | muscle fiber development (GO:0048747) | 4.25850358 |
| 59 | skeletal muscle adaptation (GO:0043501) | 4.17253860 |
| 60 | carnitine transmembrane transport (GO:1902603) | 4.16795530 |
| 61 | regulation of sequestering of triglyceride (GO:0010889) | 4.16593579 |
| 62 | ATP synthesis coupled proton transport (GO:0015986) | 4.16165669 |
| 63 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.16165669 |
| 64 | glucan catabolic process (GO:0009251) | 4.14689993 |
| 65 | muscle hypertrophy (GO:0014896) | 4.14271426 |
| 66 | electron transport chain (GO:0022900) | 4.14040747 |
| 67 | skeletal muscle tissue development (GO:0007519) | 4.11135019 |
| 68 | NADH metabolic process (GO:0006734) | 4.08601752 |
| 69 | oxidative phosphorylation (GO:0006119) | 4.02328755 |
| 70 | regulation of the force of heart contraction (GO:0002026) | 4.01992464 |
| 71 | muscle contraction (GO:0006936) | 4.01112204 |
| 72 | 2-oxoglutarate metabolic process (GO:0006103) | 4.00705510 |
| 73 | cell communication involved in cardiac conduction (GO:0086065) | 3.97676907 |
| 74 | muscle cell cellular homeostasis (GO:0046716) | 3.94853082 |
| 75 | regulation of sulfur metabolic process (GO:0042762) | 3.92078067 |
| 76 | response to inactivity (GO:0014854) | 3.90589475 |
| 77 | cellular polysaccharide catabolic process (GO:0044247) | 3.88600601 |
| 78 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.86167587 |
| 79 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.82035777 |
| 80 | carnitine transport (GO:0015879) | 3.79397303 |
| 81 | amino-acid betaine transport (GO:0015838) | 3.79397303 |
| 82 | striated muscle adaptation (GO:0014888) | 3.79381549 |
| 83 | negative regulation of potassium ion transport (GO:0043267) | 3.77594189 |
| 84 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.75621914 |
| 85 | regulation of cardiac muscle contraction (GO:0055117) | 3.73280841 |
| 86 | muscle system process (GO:0003012) | 3.71900847 |
| 87 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.70870679 |
| 88 | striated muscle cell development (GO:0055002) | 3.70172116 |
| 89 | cardiac muscle adaptation (GO:0014887) | 3.66480466 |
| 90 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.66480466 |
| 91 | muscle hypertrophy in response to stress (GO:0003299) | 3.66480466 |
| 92 | negative regulation of protein localization to cell surface (GO:2000009) | 3.66255633 |
| 93 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.65038293 |
| 94 | cardiac muscle cell action potential (GO:0086001) | 3.62775880 |
| 95 | muscle adaptation (GO:0043500) | 3.60646266 |
| 96 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.58867399 |
| 97 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.58867399 |
| 98 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.56699192 |
| 99 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.56699192 |
| 100 | striated muscle atrophy (GO:0014891) | 3.56047067 |
| 101 | regulation of heart rate (GO:0002027) | 3.55566436 |
| 102 | regulation of ATPase activity (GO:0043462) | 3.54284582 |
| 103 | regulation of ATP catabolic process (GO:1903289) | 3.54284582 |
| 104 | response to muscle activity (GO:0014850) | 3.52628471 |
| 105 | muscle atrophy (GO:0014889) | 3.51888719 |
| 106 | skeletal muscle tissue regeneration (GO:0043403) | 3.51658849 |
| 107 | muscle cell fate commitment (GO:0042693) | 3.50644856 |
| 108 | polysaccharide catabolic process (GO:0000272) | 3.48992244 |
| 109 | regulation of fatty acid oxidation (GO:0046320) | 3.47965343 |
| 110 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.47829524 |
| 111 | succinate metabolic process (GO:0006105) | 3.45539473 |
| 112 | fatty acid beta-oxidation (GO:0006635) | 3.44767252 |
| 113 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.42031346 |
| 114 | positive regulation of cation channel activity (GO:2001259) | 3.41976287 |
| 115 | relaxation of cardiac muscle (GO:0055119) | 3.41785385 |
| 116 | regulation of muscle system process (GO:0090257) | 3.39621658 |
| 117 | glycogen metabolic process (GO:0005977) | 3.37438932 |
| 118 | regulation of muscle contraction (GO:0006937) | 3.36893963 |
| 119 | * muscle organ development (GO:0007517) | 3.35553780 |
| 120 | * muscle structure development (GO:0061061) | 3.35194968 |
| 121 | glycogen catabolic process (GO:0005980) | 3.34825864 |
| 122 | positive regulation of myotube differentiation (GO:0010831) | 3.34405197 |
| 123 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.34292840 |
| 124 | cellular glucan metabolic process (GO:0006073) | 3.29871466 |
| 125 | glucan metabolic process (GO:0044042) | 3.29871466 |
| 126 | gluconeogenesis (GO:0006094) | 3.28828964 |
| 127 | regulation of heart contraction (GO:0008016) | 3.27912730 |
| 128 | cell communication by electrical coupling (GO:0010644) | 3.27911581 |
| 129 | muscle cell development (GO:0055001) | 3.24386729 |
| 130 | regulation of myoblast differentiation (GO:0045661) | 3.17694424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.59970642 |
| 2 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.58978947 |
| 3 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.42234887 |
| 4 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.35766954 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.27087180 |
| 6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.99120426 |
| 7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.99120426 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.32809277 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.21951036 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.17809741 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.91002207 |
| 12 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.90081451 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.68928283 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.60504000 |
| 15 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.25463672 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.14358296 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.09821056 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.03254649 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.00199005 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.97933042 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.86577151 |
| 22 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.81007289 |
| 23 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.78273340 |
| 24 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.73042124 |
| 25 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.72342856 |
| 26 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.68332339 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.64096331 |
| 28 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.60028571 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57675195 |
| 30 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.48684312 |
| 31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.47074796 |
| 32 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.41918080 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38319685 |
| 34 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.37829927 |
| 35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35711493 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35246404 |
| 37 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.34340642 |
| 38 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33803337 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.31556649 |
| 40 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.25089525 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22829775 |
| 42 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.22559290 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21327179 |
| 44 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.18618903 |
| 45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.17892371 |
| 46 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17603704 |
| 47 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.17240171 |
| 48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16500161 |
| 49 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.13135755 |
| 50 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09312591 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08841159 |
| 52 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.08617333 |
| 53 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.08247071 |
| 54 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07339004 |
| 55 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07058021 |
| 56 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06336633 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.06215419 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06038865 |
| 59 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.02167901 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00834797 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00629930 |
| 62 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.99279270 |
| 63 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.98439623 |
| 64 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.98142552 |
| 65 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97251157 |
| 66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96983514 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95533335 |
| 68 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.94590559 |
| 69 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94097190 |
| 70 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93483914 |
| 71 | CJUN_26792858_Chip-Seq_BT549_Human | 0.93214342 |
| 72 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.93007373 |
| 73 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.92958582 |
| 74 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.92240017 |
| 75 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.92240017 |
| 76 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.92036434 |
| 77 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91936113 |
| 78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91212784 |
| 79 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.91133926 |
| 80 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.90550985 |
| 81 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90515244 |
| 82 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89957116 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89280639 |
| 84 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.88942896 |
| 85 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.88609726 |
| 86 | P68_20966046_ChIP-Seq_HELA_Human | 0.88115417 |
| 87 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87519623 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.87110682 |
| 89 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.86882928 |
| 90 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.86009491 |
| 91 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.85444050 |
| 92 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.84618111 |
| 93 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.84289535 |
| 94 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.84076270 |
| 95 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83425938 |
| 96 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83333208 |
| 97 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82732507 |
| 98 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.82313810 |
| 99 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.81585221 |
| 100 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81548749 |
| 101 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.81209507 |
| 102 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81106524 |
| 103 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80450397 |
| 104 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.78617642 |
| 105 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.78587923 |
| 106 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78287231 |
| 107 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78083451 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.77678618 |
| 109 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.77500768 |
| 110 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.75813561 |
| 111 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.74869595 |
| 112 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.74347053 |
| 113 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.74163195 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.73842402 |
| 115 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.73643449 |
| 116 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.73558504 |
| 117 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.73013418 |
| 118 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.72685358 |
| 119 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.72438030 |
| 120 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.71279446 |
| 121 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70341929 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.70323747 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.70323747 |
| 124 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.70074827 |
| 125 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.69920183 |
| 126 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.69275242 |
| 127 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.68949594 |
| 128 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.68847776 |
| 129 | SA1_27219007_Chip-Seq_Bcells_Human | 0.68636949 |
| 130 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.68308259 |
| 131 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.68162896 |
| 132 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.67903827 |
| 133 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.67403712 |
| 134 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.67151528 |
| 135 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.67127327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.45407910 |
| 2 | MP0003646_muscle_fatigue | 6.07170847 |
| 3 | MP0000751_myopathy | 5.58777836 |
| 4 | MP0004084_abnormal_cardiac_muscle | 5.13928189 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.38516247 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.30606272 |
| 7 | * MP0000749_muscle_degeneration | 4.14234481 |
| 8 | MP0005330_cardiomyopathy | 3.75984415 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.42706623 |
| 10 | * MP0004087_abnormal_muscle_fiber | 3.25962190 |
| 11 | MP0004130_abnormal_muscle_cell | 3.01457700 |
| 12 | MP0002972_abnormal_cardiac_muscle | 2.93404965 |
| 13 | * MP0002106_abnormal_muscle_physiology | 2.89836711 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.88498548 |
| 15 | MP0003137_abnormal_impulse_conducting | 2.58939317 |
| 16 | MP0008775_abnormal_heart_ventricle | 2.57505387 |
| 17 | MP0004484_altered_response_of | 2.55691767 |
| 18 | * MP0000750_abnormal_muscle_regeneration | 2.55437634 |
| 19 | * MP0002269_muscular_atrophy | 2.45821939 |
| 20 | MP0010630_abnormal_cardiac_muscle | 2.43783017 |
| 21 | MP0005385_cardiovascular_system_phenoty | 2.42808989 |
| 22 | MP0001544_abnormal_cardiovascular_syste | 2.42808989 |
| 23 | * MP0000759_abnormal_skeletal_muscle | 2.42220764 |
| 24 | * MP0005369_muscle_phenotype | 2.36504373 |
| 25 | * MP0000747_muscle_weakness | 2.25399300 |
| 26 | MP0006138_congestive_heart_failure | 2.14490158 |
| 27 | MP0003828_pulmonary_edema | 1.98487709 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 1.98382684 |
| 29 | MP0004233_abnormal_muscle_weight | 1.97545079 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.90219160 |
| 31 | MP0004085_abnormal_heartbeat | 1.81121879 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.70673540 |
| 33 | MP0002332_abnormal_exercise_endurance | 1.70665420 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.62333710 |
| 35 | MP0004510_myositis | 1.52913150 |
| 36 | MP0005670_abnormal_white_adipose | 1.48829889 |
| 37 | MP0002127_abnormal_cardiovascular_syste | 1.43950245 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.34426590 |
| 39 | MP0004270_analgesia | 1.24178699 |
| 40 | MP0005375_adipose_tissue_phenotype | 1.18162543 |
| 41 | MP0000343_altered_response_to | 1.15898375 |
| 42 | MP0000733_abnormal_muscle_development | 1.11805246 |
| 43 | MP0002234_abnormal_pharynx_morphology | 1.10546235 |
| 44 | MP0006035_abnormal_mitochondrial_morpho | 1.08831492 |
| 45 | MP0003567_abnormal_fetal_cardiomyocyte | 1.07468594 |
| 46 | MP0001661_extended_life_span | 1.06071768 |
| 47 | * MP0000266_abnormal_heart_morphology | 1.03764151 |
| 48 | MP0005165_increased_susceptibility_to | 1.01269050 |
| 49 | MP0002971_abnormal_brown_adipose | 0.95155223 |
| 50 | MP0005266_abnormal_metabolism | 0.94906686 |
| 51 | * MP0002108_abnormal_muscle_morphology | 0.87829133 |
| 52 | MP0003279_aneurysm | 0.86757487 |
| 53 | MP0010368_abnormal_lymphatic_system | 0.83285957 |
| 54 | MP0000013_abnormal_adipose_tissue | 0.83149529 |
| 55 | MP0000230_abnormal_systemic_arterial | 0.75275360 |
| 56 | MP0000003_abnormal_adipose_tissue | 0.73415594 |
| 57 | MP0004043_abnormal_pH_regulation | 0.72303189 |
| 58 | MP0002128_abnormal_blood_circulation | 0.70336560 |
| 59 | MP0003705_abnormal_hypodermis_morpholog | 0.70107096 |
| 60 | MP0005623_abnormal_meninges_morphology | 0.69236329 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 0.66314999 |
| 62 | MP0004147_increased_porphyrin_level | 0.62561666 |
| 63 | MP0003566_abnormal_cell_adhesion | 0.59776645 |
| 64 | MP0001879_abnormal_lymphatic_vessel | 0.59697209 |
| 65 | MP0008438_abnormal_cutaneous_collagen | 0.58333202 |
| 66 | MP0002078_abnormal_glucose_homeostasis | 0.57666730 |
| 67 | MP0002909_abnormal_adrenal_gland | 0.57275095 |
| 68 | MP0005275_abnormal_skin_tensile | 0.54988185 |
| 69 | MP0005503_abnormal_tendon_morphology | 0.53046612 |
| 70 | MP0010030_abnormal_orbit_morphology | 0.48489508 |
| 71 | MP0000767_abnormal_smooth_muscle | 0.48298256 |
| 72 | MP0008961_abnormal_basal_metabolism | 0.48148601 |
| 73 | MP0005334_abnormal_fat_pad | 0.44167754 |
| 74 | MP0005535_abnormal_body_temperature | 0.43614697 |
| 75 | * MP0005319_abnormal_enzyme/_coenzyme | 0.41935436 |
| 76 | MP0000372_irregular_coat_pigmentation | 0.41488100 |
| 77 | MP0005187_abnormal_penis_morphology | 0.41419307 |
| 78 | MP0005451_abnormal_body_composition | 0.40722917 |
| 79 | MP0003941_abnormal_skin_development | 0.40524211 |
| 80 | MP0008569_lethality_at_weaning | 0.40518831 |
| 81 | MP0004272_abnormal_basement_membrane | 0.39771796 |
| 82 | MP0002896_abnormal_bone_mineralization | 0.37110126 |
| 83 | MP0009115_abnormal_fat_cell | 0.36388319 |
| 84 | MP0002925_abnormal_cardiovascular_devel | 0.36042929 |
| 85 | MP0002638_abnormal_pupillary_reflex | 0.35891960 |
| 86 | MP0009672_abnormal_birth_weight | 0.34991878 |
| 87 | MP0003948_abnormal_gas_homeostasis | 0.34911119 |
| 88 | MP0002118_abnormal_lipid_homeostasis | 0.33966554 |
| 89 | MP0003879_abnormal_hair_cell | 0.32885172 |
| 90 | MP0004134_abnormal_chest_morphology | 0.32689292 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.31265339 |
| 92 | MP0005423_abnormal_somatic_nervous | 0.31258079 |
| 93 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.31118332 |
| 94 | MP0003045_fibrosis | 0.30591660 |
| 95 | MP0001614_abnormal_blood_vessel | 0.30287544 |
| 96 | MP0001784_abnormal_fluid_regulation | 0.28451256 |
| 97 | MP0002114_abnormal_axial_skeleton | 0.28155257 |
| 98 | MP0005452_abnormal_adipose_tissue | 0.28076754 |
| 99 | MP0000762_abnormal_tongue_morphology | 0.27294819 |
| 100 | MP0009780_abnormal_chondrocyte_physiolo | 0.27038096 |
| 101 | MP0009250_abnormal_appendicular_skeleto | 0.27006938 |
| 102 | MP0003195_calcinosis | 0.26315389 |
| 103 | MP0001958_emphysema | 0.25857793 |
| 104 | MP0002877_abnormal_melanocyte_morpholog | 0.25712486 |
| 105 | MP0009840_abnormal_foam_cell | 0.24282557 |
| 106 | MP0009384_cardiac_valve_regurgitation | 0.23955003 |
| 107 | MP0001727_abnormal_embryo_implantation | 0.23856862 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.23689607 |
| 109 | MP0002970_abnormal_white_adipose | 0.23567334 |
| 110 | MP0003959_abnormal_lean_body | 0.23496673 |
| 111 | MP0001853_heart_inflammation | 0.23058277 |
| 112 | MP0003984_embryonic_growth_retardation | 0.22980668 |
| 113 | MP0005083_abnormal_biliary_tract | 0.22728429 |
| 114 | MP0002822_catalepsy | 0.22472670 |
| 115 | MP0002088_abnormal_embryonic_growth/wei | 0.22018093 |
| 116 | MP0002734_abnormal_mechanical_nocicepti | 0.21785791 |
| 117 | MP0005595_abnormal_vascular_smooth | 0.21577293 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.21202617 |
| 119 | MP0005386_behavior/neurological_phenoty | 0.21161193 |
| 120 | MP0004924_abnormal_behavior | 0.21161193 |
| 121 | MP0005376_homeostasis/metabolism_phenot | 0.21056596 |
| 122 | MP0005332_abnormal_amino_acid | 0.18727129 |
| 123 | MP0008874_decreased_physiological_sensi | 0.18404097 |
| 124 | MP0000579_abnormal_nail_morphology | 0.17468559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 6.87545976 |
| 2 | Sudden death (HP:0001699) | 6.84909034 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.72870521 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.49177538 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 6.48553878 |
| 6 | Ventricular tachycardia (HP:0004756) | 5.84004290 |
| 7 | Muscle fiber splitting (HP:0003555) | 5.83419571 |
| 8 | Myoglobinuria (HP:0002913) | 5.30498407 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 5.20467947 |
| 10 | Muscle fiber inclusion bodies (HP:0100299) | 4.99072630 |
| 11 | Atrial fibrillation (HP:0005110) | 4.93389406 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.87863802 |
| 13 | * Abnormality of the calf musculature (HP:0001430) | 4.73054508 |
| 14 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.64984434 |
| 15 | Subaortic stenosis (HP:0001682) | 4.64984434 |
| 16 | Primary atrial arrhythmia (HP:0001692) | 4.60670892 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 4.52754129 |
| 18 | Lipoatrophy (HP:0100578) | 4.52011420 |
| 19 | Difficulty running (HP:0009046) | 4.45429367 |
| 20 | Supraventricular tachycardia (HP:0004755) | 4.45091804 |
| 21 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.44552657 |
| 22 | Supraventricular arrhythmia (HP:0005115) | 4.35826991 |
| 23 | Increased connective tissue (HP:0009025) | 4.25778628 |
| 24 | Nemaline bodies (HP:0003798) | 4.24773823 |
| 25 | Right ventricular cardiomyopathy (HP:0011663) | 4.20337479 |
| 26 | Type 1 muscle fiber predominance (HP:0003803) | 4.17395940 |
| 27 | Rhabdomyolysis (HP:0003201) | 4.14226889 |
| 28 | Bundle branch block (HP:0011710) | 4.04504885 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 3.99817274 |
| 30 | Syncope (HP:0001279) | 3.90338430 |
| 31 | Dilated cardiomyopathy (HP:0001644) | 3.87521593 |
| 32 | Palpitations (HP:0001962) | 3.85234457 |
| 33 | Myotonia (HP:0002486) | 3.71099775 |
| 34 | Calcaneovalgus deformity (HP:0001848) | 3.67309775 |
| 35 | Prolonged QT interval (HP:0001657) | 3.59133214 |
| 36 | Ventricular arrhythmia (HP:0004308) | 3.38423636 |
| 37 | Heart block (HP:0012722) | 3.34189828 |
| 38 | Difficulty climbing stairs (HP:0003551) | 3.32606352 |
| 39 | Absent phalangeal crease (HP:0006109) | 3.27352171 |
| 40 | Muscle stiffness (HP:0003552) | 3.27252038 |
| 41 | Deformed tarsal bones (HP:0008119) | 3.24339501 |
| 42 | Abnormal atrioventricular conduction (HP:0005150) | 3.16439191 |
| 43 | Distal arthrogryposis (HP:0005684) | 3.14354015 |
| 44 | Atrioventricular block (HP:0001678) | 3.09842223 |
| 45 | Increased variability in muscle fiber diameter (HP:0003557) | 3.04531956 |
| 46 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.04354738 |
| 47 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.99890796 |
| 48 | Acute necrotizing encephalopathy (HP:0006965) | 2.96675924 |
| 49 | Malignant hyperthermia (HP:0002047) | 2.89374480 |
| 50 | Neck muscle weakness (HP:0000467) | 2.88776483 |
| 51 | Hepatic necrosis (HP:0002605) | 2.87060382 |
| 52 | Ventricular fibrillation (HP:0001663) | 2.86838888 |
| 53 | Areflexia of lower limbs (HP:0002522) | 2.80463744 |
| 54 | Round ear (HP:0100830) | 2.75770797 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 2.75060395 |
| 56 | Myopathic facies (HP:0002058) | 2.74913643 |
| 57 | Abnormal finger flexion creases (HP:0006143) | 2.73305193 |
| 58 | Ketoacidosis (HP:0001993) | 2.59886517 |
| 59 | Acute encephalopathy (HP:0006846) | 2.58484661 |
| 60 | Abnormal EKG (HP:0003115) | 2.56451013 |
| 61 | Left ventricular hypertrophy (HP:0001712) | 2.55573082 |
| 62 | Rimmed vacuoles (HP:0003805) | 2.49897620 |
| 63 | Progressive macrocephaly (HP:0004481) | 2.48701617 |
| 64 | Limb-girdle muscle atrophy (HP:0003797) | 2.47863769 |
| 65 | Hypoglycemic coma (HP:0001325) | 2.46642093 |
| 66 | Hepatocellular necrosis (HP:0001404) | 2.46402481 |
| 67 | Fetal akinesia sequence (HP:0001989) | 2.44233215 |
| 68 | Weak cry (HP:0001612) | 2.36615572 |
| 69 | Increased muscle lipid content (HP:0009058) | 2.36422310 |
| 70 | Slender build (HP:0001533) | 2.34559810 |
| 71 | Mitochondrial inheritance (HP:0001427) | 2.32128868 |
| 72 | Cerebral edema (HP:0002181) | 2.31237224 |
| 73 | Abnormality of the neuromuscular junction (HP:0003398) | 2.28131182 |
| 74 | Fatigable weakness (HP:0003473) | 2.28131182 |
| 75 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.27695271 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.26383698 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.26383698 |
| 78 | Ulnar deviation of the wrist (HP:0003049) | 2.26092698 |
| 79 | Exercise intolerance (HP:0003546) | 2.23579878 |
| 80 | Facial diplegia (HP:0001349) | 2.23564296 |
| 81 | Spinal rigidity (HP:0003306) | 2.23553852 |
| 82 | Conjunctival hamartoma (HP:0100780) | 2.20114030 |
| 83 | Palmoplantar keratoderma (HP:0000982) | 2.19812167 |
| 84 | Increased CSF lactate (HP:0002490) | 2.19809011 |
| 85 | Generalized muscle weakness (HP:0003324) | 2.19259576 |
| 86 | Hypoplastic ischia (HP:0003175) | 2.17994562 |
| 87 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.16096268 |
| 88 | Abnormality of alanine metabolism (HP:0010916) | 2.16096268 |
| 89 | Hyperalaninemia (HP:0003348) | 2.16096268 |
| 90 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.15749705 |
| 91 | Testicular atrophy (HP:0000029) | 2.15660991 |
| 92 | Muscular dystrophy (HP:0003560) | 2.14916774 |
| 93 | EMG: neuropathic changes (HP:0003445) | 2.14679914 |
| 94 | Distal lower limb amyotrophy (HP:0008944) | 2.14535957 |
| 95 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.07675681 |
| 96 | Waddling gait (HP:0002515) | 2.04621886 |
| 97 | Scapular winging (HP:0003691) | 2.04252500 |
| 98 | Increased intramyocellular lipid droplets (HP:0012240) | 2.03484648 |
| 99 | Frequent falls (HP:0002359) | 2.02735600 |
| 100 | Abnormality of the calcaneus (HP:0008364) | 2.02676148 |
| 101 | Lactic acidosis (HP:0003128) | 2.02673240 |
| 102 | Hip contracture (HP:0003273) | 2.01462832 |
| 103 | Hyperkalemia (HP:0002153) | 1.98653291 |
| 104 | Proximal amyotrophy (HP:0007126) | 1.98595400 |
| 105 | Respiratory failure (HP:0002878) | 1.95332436 |
| 106 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.94562496 |
| 107 | Ketosis (HP:0001946) | 1.94339520 |
| 108 | Ragged-red muscle fibers (HP:0003200) | 1.93476125 |
| 109 | Pheochromocytoma (HP:0002666) | 1.93430017 |
| 110 | Progressive muscle weakness (HP:0003323) | 1.91571369 |
| 111 | Abnormality of the ischium (HP:0003174) | 1.89488549 |
| 112 | * Gowers sign (HP:0003391) | 1.88057674 |
| 113 | Lower limb amyotrophy (HP:0007210) | 1.87039833 |
| 114 | Abnormality of the foot musculature (HP:0001436) | 1.86789791 |
| 115 | Foot dorsiflexor weakness (HP:0009027) | 1.84239669 |
| 116 | Popliteal pterygium (HP:0009756) | 1.82474161 |
| 117 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.81186702 |
| 118 | Limb-girdle muscle weakness (HP:0003325) | 1.79576676 |
| 119 | Bulbar palsy (HP:0001283) | 1.79347742 |
| 120 | Neoplasm of head and neck (HP:0012288) | 1.79230656 |
| 121 | Steppage gait (HP:0003376) | 1.75866763 |
| 122 | Oligomenorrhea (HP:0000876) | 1.58209328 |
| 123 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.56447622 |
| 124 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.56447622 |
| 125 | Metatarsus adductus (HP:0001840) | 1.55621555 |
| 126 | Type 2 muscle fiber atrophy (HP:0003554) | 1.54898772 |
| 127 | Shoulder girdle muscle weakness (HP:0003547) | 1.52429576 |
| 128 | Nonprogressive disorder (HP:0003680) | 1.48367890 |
| 129 | Muscle fiber atrophy (HP:0100295) | 1.47103931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.55688111 |
| 2 | OBSCN | 5.37562057 |
| 3 | PHKG2 | 4.44445922 |
| 4 | PHKG1 | 4.44445922 |
| 5 | PDK3 | 3.53246859 |
| 6 | PDK4 | 3.53246859 |
| 7 | LMTK2 | 3.08224660 |
| 8 | TRIB3 | 2.92390597 |
| 9 | MYLK | 2.82899155 |
| 10 | DMPK | 2.76313175 |
| 11 | PKN2 | 2.66098776 |
| 12 | BCKDK | 2.62462010 |
| 13 | MUSK | 2.46612851 |
| 14 | NEK1 | 2.30450605 |
| 15 | PINK1 | 2.25577584 |
| 16 | PDK2 | 2.18023572 |
| 17 | PIK3CA | 2.08378071 |
| 18 | TIE1 | 1.74764227 |
| 19 | STK24 | 1.63338065 |
| 20 | LIMK1 | 1.44759047 |
| 21 | MAP3K7 | 1.35844708 |
| 22 | MAP2K3 | 1.35505007 |
| 23 | MARK1 | 1.35360404 |
| 24 | PIK3CG | 1.30202650 |
| 25 | GRK7 | 1.29844697 |
| 26 | MAPK12 | 1.25487956 |
| 27 | NME1 | 1.21707524 |
| 28 | EEF2K | 1.11564822 |
| 29 | PAK3 | 1.10093168 |
| 30 | ILK | 1.09395084 |
| 31 | PRKD1 | 1.08406255 |
| 32 | CAMK2D | 1.07305003 |
| 33 | PRKAA2 | 0.92219998 |
| 34 | PRKAA1 | 0.91859656 |
| 35 | MAPKAPK3 | 0.89578951 |
| 36 | ROCK1 | 0.84343293 |
| 37 | TRPM7 | 0.82992933 |
| 38 | MOS | 0.81223569 |
| 39 | INSRR | 0.77312362 |
| 40 | RIPK1 | 0.75549162 |
| 41 | MAP3K5 | 0.74910148 |
| 42 | ZAK | 0.72644796 |
| 43 | MAP3K3 | 0.72561257 |
| 44 | FLT3 | 0.69925852 |
| 45 | PKN1 | 0.66792215 |
| 46 | WNK4 | 0.66724743 |
| 47 | CDC42BPA | 0.66514293 |
| 48 | STK4 | 0.65502000 |
| 49 | CAMK2B | 0.64563692 |
| 50 | NEK9 | 0.64201339 |
| 51 | DYRK1B | 0.64056971 |
| 52 | CAMK4 | 0.63802988 |
| 53 | MAPK4 | 0.62891674 |
| 54 | PDGFRA | 0.60180897 |
| 55 | CCNB1 | 0.59629470 |
| 56 | EPHB1 | 0.58664145 |
| 57 | STK38L | 0.58382713 |
| 58 | NME2 | 0.56629211 |
| 59 | TGFBR2 | 0.53166662 |
| 60 | DAPK3 | 0.53150620 |
| 61 | ROCK2 | 0.51819400 |
| 62 | CAMK2A | 0.50290975 |
| 63 | RPS6KB2 | 0.50154899 |
| 64 | KSR2 | 0.48628513 |
| 65 | ERBB3 | 0.48269963 |
| 66 | AKT2 | 0.48087968 |
| 67 | STK38 | 0.47733061 |
| 68 | MAP2K4 | 0.47124654 |
| 69 | PRKACB | 0.46267791 |
| 70 | SIK1 | 0.45158144 |
| 71 | WNK1 | 0.45112751 |
| 72 | CAMK2G | 0.44635109 |
| 73 | PDPK1 | 0.41138478 |
| 74 | RPS6KC1 | 0.40010534 |
| 75 | RPS6KL1 | 0.40010534 |
| 76 | CAMK1 | 0.39101140 |
| 77 | TESK1 | 0.38827485 |
| 78 | KDR | 0.38273675 |
| 79 | PRKACA | 0.37038613 |
| 80 | PTK6 | 0.36838953 |
| 81 | PTK2B | 0.36319005 |
| 82 | SCYL2 | 0.35376186 |
| 83 | MAP3K6 | 0.35044320 |
| 84 | MAP2K6 | 0.34728915 |
| 85 | PRKACG | 0.34422035 |
| 86 | PDK1 | 0.34327580 |
| 87 | RPS6KA6 | 0.33002344 |
| 88 | ICK | 0.31369186 |
| 89 | TBK1 | 0.28553355 |
| 90 | MAPK11 | 0.27446962 |
| 91 | PRKCE | 0.26617319 |
| 92 | RPS6KB1 | 0.25941347 |
| 93 | MAP3K13 | 0.25515748 |
| 94 | STK39 | 0.25138941 |
| 95 | RPS6KA1 | 0.24185929 |
| 96 | RPS6KA2 | 0.23206430 |
| 97 | SGK2 | 0.22216366 |
| 98 | MAPK10 | 0.22037923 |
| 99 | MAP2K2 | 0.21821926 |
| 100 | PRKCH | 0.20833515 |
| 101 | PRKG1 | 0.20530949 |
| 102 | ARAF | 0.20328921 |
| 103 | SGK1 | 0.19788509 |
| 104 | MTOR | 0.19656536 |
| 105 | JAK1 | 0.18789313 |
| 106 | LATS2 | 0.18710424 |
| 107 | MARK2 | 0.18468469 |
| 108 | RPS6KA3 | 0.18372439 |
| 109 | MAPK7 | 0.17915968 |
| 110 | TAOK2 | 0.17418789 |
| 111 | RET | 0.16929957 |
| 112 | LATS1 | 0.16903485 |
| 113 | FER | 0.16764232 |
| 114 | EPHA3 | 0.16742553 |
| 115 | SGK3 | 0.15882191 |
| 116 | LRRK2 | 0.15490396 |
| 117 | TAOK1 | 0.14951768 |
| 118 | PRPF4B | 0.14400310 |
| 119 | FGFR4 | 0.13832429 |
| 120 | MAP3K11 | 0.13609636 |
| 121 | MAP2K1 | 0.12950880 |
| 122 | MAP3K1 | 0.12252490 |
| 123 | EPHB2 | 0.11551011 |
| 124 | CAMK1D | 0.11198330 |
| 125 | PRKG2 | 0.09895994 |
| 126 | CAMK1G | 0.08808543 |
| 127 | MAPK9 | 0.08606855 |
| 128 | RAF1 | 0.07964456 |
| 129 | PAK6 | 0.06124302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.99241899 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.27641157 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.14087186 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.51614219 |
| 5 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.39264597 |
| 6 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.38717083 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 3.26268010 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.18308297 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.04640514 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.96069285 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.52616188 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.49803858 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.46837855 |
| 14 | * Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.35282300 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.33026667 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.25983267 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 2.01303825 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.84775046 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61899944 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.59825475 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.44616303 |
| 22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.31094445 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29420516 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23094300 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22684510 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.21007799 |
| 27 | Insulin resistance_Homo sapiens_hsa04931 | 1.19197553 |
| 28 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.15258962 |
| 29 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.15092333 |
| 30 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.14484675 |
| 31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12800602 |
| 32 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.06614585 |
| 33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94729815 |
| 34 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.85663495 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.81955963 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.80941355 |
| 37 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.79086322 |
| 38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78547488 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76880617 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.76040263 |
| 41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.73706998 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72500780 |
| 43 | Focal adhesion_Homo sapiens_hsa04510 | 0.71018467 |
| 44 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67255511 |
| 45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66958405 |
| 46 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65275351 |
| 47 | Lysine degradation_Homo sapiens_hsa00310 | 0.65257238 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 0.61324606 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60428669 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59899983 |
| 51 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55428304 |
| 52 | Tight junction_Homo sapiens_hsa04530 | 0.54959206 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54636554 |
| 54 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53959747 |
| 55 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49841157 |
| 56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.48768950 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47893742 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.46762282 |
| 59 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46051976 |
| 60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45635870 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 0.43622398 |
| 62 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.41111541 |
| 63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40480816 |
| 64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38034805 |
| 65 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.37729826 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37648069 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36302757 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.36111279 |
| 69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.32864174 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.32310404 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.30941815 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30129052 |
| 73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28747982 |
| 74 | Insulin secretion_Homo sapiens_hsa04911 | 0.28649234 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27477997 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.27047680 |
| 77 | Melanogenesis_Homo sapiens_hsa04916 | 0.25895579 |
| 78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25866660 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.25611256 |
| 80 | Adherens junction_Homo sapiens_hsa04520 | 0.24832770 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.24676987 |
| 82 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.24298347 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21432086 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.20660655 |
| 85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.19521509 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.18697921 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.18504006 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17999407 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.17667001 |
| 90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.16709482 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.16660307 |
| 92 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.16624060 |
| 93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.16420544 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.15915471 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.15857365 |
| 96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15497651 |
| 97 | Long-term depression_Homo sapiens_hsa04730 | 0.15066589 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.15047013 |
| 99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.14802933 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.12604990 |
| 101 | Circadian entrainment_Homo sapiens_hsa04713 | 0.11591980 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.07874265 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.07375035 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.06909128 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.06116346 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.06104530 |
| 107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.05661805 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.05603654 |
| 109 | Gap junction_Homo sapiens_hsa04540 | 0.04921360 |
| 110 | Bile secretion_Homo sapiens_hsa04976 | 0.04853314 |
| 111 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.04774161 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.02973831 |
| 113 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.02536340 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.01013103 |
| 115 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0216069 |
| 116 | Sulfur metabolism_Homo sapiens_hsa00920 | -0.0188069 |

